However, in intermittent periods between these paroxysmal symptoms, most patients with ATP1A3‐related disorders present with persistent neurological deficits such as hypotonia, motor delay, ataxia, nystagmus, cognitive and behavioural dysfunction, or involuntary movements such as dystonia or choreoathetosis.1 The gene discussed is ATP1A3; the disease is cerebellar ataxia.